Missedย NVDA?
Donโt Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities โ for free.
Home โบ Stocks โบ Ingevity Corporation (NGVT) Stock Forecast & Price Prediction United States | NYSE | Basic Materials | Specialty Chemicals
$75.17
+0.66 (0.89%)Did NGVT Make This Month's Elite Buy List?
We don't follow just any analyst โ only the top 3% with a proven track record make our cut. See if Ingevity is one of their latest high-conviction picks.
Based on our analysis of 2 Wall Street analysts, NGVT has a bullish consensus with a median price target of $90.00 (ranging from $85.00 to $92.00). The overall analyst rating is Strong Buy (9.3/10). Currently trading at $75.17, the median forecast implies a 19.7% upside. This outlook is supported by 3 Buy, 0 Hold, and 0 Sell ratings.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for NGVT.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Feb 27, 2026 | Wells Fargo | Michael Sison | Equal-Weight | Maintains | $75.00 |
| Jan 29, 2026 | Wells Fargo | Equal-Weight | Maintains | $N/A | |
| Dec 19, 2025 | Wells Fargo | Equal-Weight | Maintains | $N/A | |
| Dec 10, 2025 | BMO Capital | Outperform | Maintains | $N/A | |
| Nov 12, 2025 | Wells Fargo | Equal-Weight | Maintains | $N/A | |
| Sep 5, 2025 | BMO Capital | Outperform | Maintains | $N/A | |
| Aug 7, 2025 | BMO Capital | Outperform | Maintains | $N/A | |
| Jul 14, 2025 | Wells Fargo | Equal-Weight | Maintains | $N/A | |
| May 7, 2025 | Wells Fargo | Equal-Weight | Maintains | $N/A | |
| Apr 9, 2025 | Wells Fargo | Equal-Weight | Maintains | $N/A | |
| Feb 26, 2025 | BMO Capital | Outperform | Upgrade | $N/A | |
| Feb 20, 2025 | BMO Capital | Market Perform | Maintains | $N/A | |
| Oct 31, 2024 | BMO Capital | Market Perform | Maintains | $N/A | |
| Sep 30, 2024 | BMO Capital | Market Perform | Maintains | $N/A | |
| Aug 5, 2024 | BMO Capital | Market Perform | Maintains | $N/A | |
| Aug 5, 2024 | Wells Fargo | Equal-Weight | Maintains | $N/A | |
| Aug 1, 2024 | Oppenheimer | Outperform | Maintains | $N/A | |
| Jul 11, 2024 | Wells Fargo | Equal-Weight | Maintains | $N/A | |
| May 8, 2024 | BMO Capital | Market Perform | Maintains | $N/A | |
| May 7, 2024 | Loop Capital | Hold | Maintains | $N/A |
The following stocks are similar to Ingevity based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Ingevity Corporation has a market capitalization of $2.61B with a P/E ratio of 13.0x. The company generates $1.18B in trailing twelve-month revenue with a -10.9% profit margin.
Revenue growth is +4.1% quarter-over-quarter, while maintaining an operating margin of +26.7% and return on equity of -114.1%.
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings โ tracked and updated every Monday and Thursday.
Manufactures specialty chemicals and carbon materials.
Ingevity Corporation generates revenue by producing specialty chemicals and high-performance carbon materials. It primarily serves industries such as automotive, construction, and industrial applications, focusing on solutions that enhance product performance and sustainability. The company's activated carbon products help reduce vehicle emissions, while its chemical solutions are essential in various applications including adhesives and lubricants.
With a rich history of expertise, Ingevity emphasizes sustainability through both its product offerings and responsible manufacturing processes. The company plays a crucial role in the specialty chemicals market, providing essential raw materials that promote efficiency and environmental responsibility across multiple sectors.
Basic Materials
Specialty Chemicals
1,400
Mr. David H. Li
United States
2016
NGVT shares are up 24.8% YTD, beating the industry, as portfolio optimization, hybrid demand and pricing actions drive earnings and boost outlook.
NGVT shares have risen 24.8% year-to-date, outperforming the industry due to portfolio optimization, hybrid demand, and pricing strategies enhancing earnings and outlook.
NGVT's 24.8% YTD share increase signals strong performance and positive outlook, driven by effective strategies, making it an attractive prospect for investment.
Ingevity's CEO, Dave Li, will speak at the 2026 Wells Fargo Industrials & Materials Conference on June 11.
Dave Li's participation in a key industry conference may signal updates on Ingevity's strategy and performance, influencing investor sentiment and potential stock movement.
Ingevity (NGVT) recently reported earnings, and investors may be looking for insights on the stock's future performance following this update.
Earnings reports can impact stock price volatility and investor sentiment. Upcoming guidance or analyst reactions will influence market expectations and stock performance for Ingevity.
Ingevity (NYSE: NGVT) reported increased Q1 2026 sales and confirmed its full-year outlook, citing portfolio simplification, strong Performance Materials margins, and ongoing share repurchases.
Ingevity's sales growth and reaffirmed outlook indicate strong business performance, which may boost investor confidence. Portfolio simplification and share repurchases could enhance shareholder value.
Ingevity surpassed Q1 estimates due to pricing actions and foreign exchange gains, though it faced challenges in Road Markings and lower asset utilization.
Ingevity's Q1 performance exceeds expectations, driven by pricing strategies and favorable FX impacts, signaling resilience despite challenges in certain sectors, which may boost investor confidence.
Ingevity Corporation (NGVT) held its Q1 2026 earnings call, discussing financial performance and key metrics. Further details on earnings will be available in the full transcript.
Earnings calls provide insights into a company's financial health and future outlook, influencing stock performance and investment decisions. Investors should assess Ingevity's Q1 2026 results for growth potential.
Based on our analysis of 2 Wall Street analysts, Ingevity Corporation (NGVT) has a median price target of $90.00. The highest price target is $92.00 and the lowest is $85.00.
According to current analyst ratings, NGVT has 3 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $75.17. Always conduct your own research and consider your investment goals before making investment decisions.
Wall Street analysts predict NGVT stock could reach $90.00 in the next 12 months. This represents a 19.7% increase from the current price of $75.17. Please note that this is a projection by Wall Street analysts and not a guarantee.
Ingevity Corporation generates revenue by producing specialty chemicals and high-performance carbon materials. It primarily serves industries such as automotive, construction, and industrial applications, focusing on solutions that enhance product performance and sustainability. The company's activated carbon products help reduce vehicle emissions, while its chemical solutions are essential in various applications including adhesives and lubricants.
The highest price target for NGVT is $92.00 from at , which represents a 22.4% increase from the current price of $75.17.
The lowest price target for NGVT is $85.00 from at , which represents a 13.1% increase from the current price of $75.17.
The overall analyst consensus for NGVT is bullish. Out of 2 Wall Street analysts, 3 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $90.00.
Stock price projections, including those for Ingevity Corporation, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.